A Suggested Ideal Defect-Free VTE Process Quality Measure This process measure should have 3 components: (1) documentation of a standardized VTE risk assessment; (2) prescription of optimal, risk-appropriate VTE prophylaxis; and (3) administration of every dose of risk-appropriate VTE prophylaxis as prescribed.
What are VTE quality measures?
The venous thromboembolism (VTE) measures were developed as a result of the ‘National Consensus Standards for the Prevention and Care of Deep Vein Thrombosis (DVT)’ project between The Joint Commission and the National Quality Forum (NQF) that formally began in January 2005.
What are the 3 proven methods to prevent VTE in the hospital setting?
Methods of DVT prophylaxis include general measures: the use of aspirin, mechanical prevention with graduated compression stockings, and intermittent pneumatic compression devices.
What is VTE protocol?
A VTE prevention protocol includes a VTE risk assessment, a bleeding risk assessment, and clinical decision support (CDS) on prophylactic choices based on the combination of VTE and bleeding risk factors.
What is VTE?
Venous thromboembolism (VTE), a term referring to blood clots in the veins, is an underdiagnosed and serious, yet preventable medical condition that can cause disability and death.
What are core measures examples?
Examples of Core Measures
- VTE prophylaxis – stroke patients received treatment to keep blood clots from forming anywhere in the body within two days of arriving at the hospital.
- Discharged on Antithrombotic Therapy – stroke patients received prescription before discharge for a medication known to prevent blood clots.
What is the goal of core measures?
The overall goal of the core measures program is to ensure that the right patient receives the best care in a timely manner every time. The core measures program was designed to remove variation from care processes, increase collaboration across the continuum of care, and enhance the quality of patient care.
What is VTE prevention?
VTEs often are preventable, with strategies that stop the development of clots in people “at-risk.” Healthcare professionals discern risk by gathering information about a patient’s age, weight, medical history, medications and lifestyle factors.
What are the methods of VTE prevention?
The measures for prevention of VTE include mechanical methods (graduated compression stockings and intermittent pneumatic compression devices) and pharmacologic agents. A combination of mechanical and pharmacologic methods produces the best results.
What is VTE assessment?
VTE risk assessment is essentially a tool. Patients are targeted for interventions to prevent VTE (anticoagulant or mechanical prophylaxis and efforts to improve mobility) based on the assessment of risk of a VTE event.
Why is VTE assessment important?
A patient assessed to be at risk of VTE has a prevention plan developed that balances the risk of thrombosis against the risk and consequences of bleeding (as an adverse effect of VTE prevention medicines). Other contraindications to VTE prevention methods are also considered before offering any to the patient.
What is the history of the VTE measure set?
History of the VTE Measure Set • TJC began testing VTE measure set in 2005 • NQF endorsement May 2008 • Hospitals were offered the measures for selection of their ORYX projects in May 2009 • Many QI projects have tested similar process and outcome measures over the last 5- 7 years • Data collection begins with Q1 2013 discharges 2
What is the VTE prophylaxis assessment measure?
This measure assesses the number of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission Inpatient hospitalizations for all patients in the initial population
What are venous thromboembolism (VTE) measures?
The venous thromboembolism (VTE) measures were developed as a result of the ‘National Consensus Standards for the Prevention and Care of Deep Vein Thrombosis (DVT)’ project between The Joint Commission and the National Quality Forum (NQF) that formally began in January 2005.
When is a completed risk assessment an acceptable source for VTE?
• A completed risk assessment within this timeframe is an acceptable source for this data element, if it is clear that the patient is a low risk for VTE and does not need VTE prophylaxis. If there is conflicting information about the need for prophylaxis, select “No”.
